Nicaragua vs Syria: HIV-positive TB patients on ART (antiretroviral therapy)
Nicaragua
100.0%
in 2023
Syria
100.0%
in 2021
Nicaragua rank
1st
Syria rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Nicaragua
- Syria
How they compare
Nicaragua currently reports 100.0% against 100.0% in Syria, a difference of 0.0%.
Across all 9 years both countries report, Syria has been ahead every year.
Nicaragua ranks 1st and Syria ranks 1st of 144 countries.
Syria has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Nicaragua | Syria | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 90.3% | 100.0% | 9.7% | Syria |
| 2020s | 98.5% | 100.0% | 1.5% | Syria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Nicaragua or Syria?
- Nicaragua, at 100.0% against 100.0% in Syria as of 2023.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Nicaragua and Syria?
- 0.0%, with Nicaragua ahead.
- How many years of comparable data are there for Nicaragua and Syria?
- 9 years are reported by both, from 2011 to 2021.
- How do Nicaragua and Syria rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Nicaragua ranks 1st and Syria ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.